Literature DB >> 17210781

Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis.

Jeremy Goldman1, Joseph M Rutkowski, Jacqueline D Shields, Miriella C Pasquier, Yingjie Cui, Hugo G Schmökel, Stephen Willey, Daniel J Hicklin, Bronislaw Pytowski, Melody A Swartz.   

Abstract

Activation of vascular endothelial growth factor (VEGF) receptor-3 (VEGFR-3) by VEGF-C initiates lymphangiogenesis by promoting lymphatic proliferation and migration. However, it is unclear whether VEGFR-3 signaling is required beyond these initial stages, namely during the organization of new lymphatic endothelial cells (LECs) into functional capillaries. Furthermore, the role of VEGFR-2, which is also expressed on LECs and binds VEGF-C, is unclear. We addressed these questions by selectively neutralizing VEGFR-3 and/or VEGFR-2 for various time periods in an adult model of lymphangiogenesis in regenerating skin. While blocking either VEGFR-2 or VEGFR-3 with specific antagonist mAbs (DC101 and mF4-31C1, respectively) prior to lymphatic migration prevented lymphangiogenesis, blocking VEGFR-3 subsequent to migration did not affect organization into functional capillaries, and VEGFR-2 blocking had only a small hindrance on organization. These findings were confirmed in vitro using human LECs and anti-human antagonist mAbs (IMC-1121a and hF4-3C5): both VEGFR-2 and -3 signaling were required for migration and proliferation, but tubulogenesis in 3D cultures was unaffected by VEGFR-3 blocking and partially hindered by VEGFR-2 blocking. Furthermore, both in vitro and in vivo, while VEGFR-3 blocking had no effect on LEC organization, coneutralization of VEGFR-2, and VEGFR-3 completely prevented lymphatic organization. Our findings demonstrate that cooperative signaling of VEGFR-2 and -3 is necessary for lymphatic migration and proliferation, but VEGFR-3 is redundant with VEGFR-2 for LEC organization into functional capillaries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210781     DOI: 10.1096/fj.06-6656com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Watching lymphatic vessels grow by making them glow.

Authors:  Steven T Proulx; Michael Detmar
Journal:  Cell Res       Date:  2011-11-29       Impact factor: 25.617

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Regulation of inflammation and fibrosis by macrophages in lymphedema.

Authors:  Swapna Ghanta; Daniel A Cuzzone; Jeremy S Torrisi; Nicholas J Albano; Walter J Joseph; Ira L Savetsky; Jason C Gardenier; David Chang; Jamie C Zampell; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

4.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

5.  Biomaterial guides for lymphatic endothelial cell alignment and migration.

Authors:  Echoe M Bouta; Connor W McCarthy; Alexander Keim; Han Bing Wang; Ryan J Gilbert; Jeremy Goldman
Journal:  Acta Biomater       Date:  2010-10-23       Impact factor: 8.947

Review 6.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

Review 7.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

8.  Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.

Authors:  Sanjeev A Datar; Eric G Johnson; Peter E Oishi; Michael Johengen; Eric Tang; Angela Aramburo; Jubilee Barton; Hsuan-Chang Kuo; Stephen Bennett; Konstantine Xoinis; Bhupinder Reel; Gokhan Kalkan; Eniko Sajti; Oscar Osorio; Gary W Raff; Michael A Matthay; Jeffrey R Fineman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-29       Impact factor: 5.464

Review 9.  Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases.

Authors:  Daniyal J Jafree; David A Long
Journal:  J Am Soc Nephrol       Date:  2020-04-15       Impact factor: 10.121

10.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.